I absolutely agree with you @MandB. Whilst PIQ have there own things going on, DXB + PIQ Promarker D is the ultimate package deal for predictive CKD & early treatment, hence either delaying or reversing (hopefully) later stages of CKD. This is huge! I’m so glad that others see that. There are a few of us invested mutually with both companies. .
I know I’ve posted recent articles here b4, however for new people...you can see why & this is only in the USA. Patent licences until 2030 as @Aqua65. The rise in type 2 diabetes is a big health problem.
Fast tracking for CKD trials, it’s a huge problem. Looking at the big picture here: https://www.prnewswire.com/news-rel...-treatments-for-kidney-disease-300615267.html
- Forums
- ASX - By Stock
- Ann: CMO Appointment and Clinical Trials Update
I absolutely agree with you @MandB. Whilst PIQ have there own...
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
35.0¢ |
Change
-0.025(6.67%) |
Mkt cap ! $25.68M |
Open | High | Low | Value | Volume |
37.0¢ | 37.0¢ | 35.0¢ | $387.8K | 1.079M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 394907 | 35.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.5¢ | 15948 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 75000 | 0.086 |
4 | 139056 | 0.085 |
2 | 158037 | 0.084 |
1 | 50000 | 0.083 |
2 | 29695 | 0.082 |
Price($) | Vol. | No. |
---|---|---|
0.087 | 1995 | 1 |
0.090 | 50000 | 1 |
0.091 | 76873 | 1 |
0.092 | 99798 | 1 |
0.093 | 50000 | 1 |
Last trade - 16.10pm 12/12/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |